• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Liver Res . The clinical implication of gamma-glutamyl transpeptidase in COVID-19

tetano

Editor, Senior Moderator
Liver Res


. 2021 Sep 25.
doi: 10.1016/j.livres.2021.09.001. Online ahead of print.
The clinical implication of gamma-glutamyl transpeptidase in COVID-19


Jianrong Liu[SUP] 1 2 [/SUP], Chao Yu[SUP] 3 4 [/SUP], Qing Yang[SUP] 1 5 [/SUP], Xiaofeng Yuan[SUP] 1 2 [/SUP], Fan Yang[SUP] 6 7 8 [/SUP], Panlong Li[SUP] 3 6 [/SUP], Guihua Chen[SUP] 1 9 10 [/SUP], Weicheng Liang[SUP] 3 6 [/SUP], Yang Yang[SUP] 1 9 10 [/SUP]



Affiliations

Abstract

Background and aim: Coronavirus disease 2019 (COVID-19) is a life-threatening disease that predominantly causes respiratory failure. The impact of COVID-19 on other organs remains elusive. Herein, we aimed to investigate the effects of COVID-19 on the hepatobiliary system.
Methods: In the current study, we obtained the clinical records and laboratory results from 66 laboratory-confirmed patients with COVID-19 at the Wuhan Tongji Hospital between 10 February 2020 and 28 February 2020. The detailed clinical features and laboratory findings were collected for analysis. Bioinformatics analysis was conducted to evaluate the correlation between gamma-glutamyl transferase (GGT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry receptor angiotensin-converting enzyme 2 (ACE2).
Results: In this cohort, 30 (51.7%) patients had abnormal liver function on admission, which was associated with disease severity and enriched in the male and diabetic patients. The elevated levels of direct bilirubin (P = 0.029) and GGT (P = 0.004) were common in patients with severe pneumonia when compared with those with mild pneumonia. In addition, elevated levels of GGT (P = 0.003) and aspartate aminotransferase (AST) (P = 0.007) were positively associated with longer hospital stay. The expression of ACE2 was closely associated with GGT in various human tissues because they shared the common transcriptional regulator hepatic nuclear factor-1β (HNF1B).
Conclusions: Increased GGT levels were common in severe cases and elevated GGT levels were positively associated with prolonged hospital stay and disease severity. Due to the consistent expression with ACE2, GGT is a potent biomarker indicating the susceptibility of SARS-CoV-2 infection.

Keywords: Angiotensin-converting enzyme 2 (ACE2); Bile duct injury; Coronavirus disease 2019 (COVID-19); Gamma-glutamyl transpeptidase (GGT); Liver injury; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
 
Back
Top Bottom